Bango

Visit/492931/if-youd-invested-in-astrazeneca-and-mitie-group
908_Good
Share tips

If you'd invested in: AstraZeneca and Mitie Group

Pharmaceutical giant AstraZeneca is expected to grow its earnings, while outsourcer Mitie's share rice has been hit by a series of profit warnings.
10 Aug 2018
Visit/473656/how-to-profit-as-britain-piles-on-the-pounds
864-CS-634
Economy

How to profit as Britain piles on the pounds

The world is getting fatter – and with no easy solution to obesity in sight, investing in healthcare providers and food and drink makers could bring b…
28 Sep 2017
Visit/470926/major-setback-for-astrazeneca
171026-Flags-634
Stockmarkets

Major setback for AstraZeneca

Pharma giant AstraZeneca was banking on a key clinical trial for its cancer drugs. It was a flop. What comes next? asks Alice Gråhns.
4 Aug 2017
Visit/349559/americas-clampdown-on-tax-inversions
US Economy

America's clampdown on tax inversions

The US government has issued new rules making it harder for American companies to cut their tax bill by relocating their headquarters.
25 Sep 2014
Advertisement
Visit/332056/money-morning-cancer-treatment-astrazeneca-azn
140801-cancer
Share tips

A revolutionary new cancer treatment – and the blue-chip stock set to benefit

A new kind of cancer therapy could make a big difference to survival rates - and transform the fortunes of one big UK drugs company. Matthew Partridge…
1 Aug 2014
Visit/327344/the-rise-of-tax-inversion
Economy

The rise of ‘tax inversion’

More and more American businesses are snapping up companies in low-tax countries to make that their official home. British companies are in their sigh…
27 Jun 2014
Advertisement
Visit/322247/astra-rebuffs-final-pfizer-bid
Stocks and shares

Astra rebuffs 'final' Pfizer bid

US drugs giant Pfizer's attempt to takeover AstraZeneca has come to a dead-end.
22 May 2014
Visit/321085/astrazeneca-fight-rumbles-on
Stocks and shares

AstraZeneca fight rumbles on

The proposed takeover of AstraZeneca is proving to be one of the most controversial yet.
15 May 2014

Subscribe to MoneyWeek

Become a smarter, better informed investor with MoneyWeek.
Visit/319973/profile-of-ian-read
Profiles

How Ian Read launched a raid on Britain’s national champion

As the head of US pharma giant Pfizer, Ian Read has led the takeover bid for Britain's AstraZeneca. But is the British-born boss driven by revenge?
14 May 2014
Advertisement
Visit/319797/company-in-the-news-astrazeneca
Share tips

Company in the news: AstraZeneca

Drugs giant AstraZeneca is at the centre of a takeover tussle with US rival Pfizer. Phil Oakley looks at how the shares have been affected.
9 May 2014
Visit/317787/money-morning-buy-big-pharma-stocks
Share tips

Buy Big Pharma – the deal spree could be just beginning

With pharmaceutical stocks still looking cheap and some very smart deals being done, it’s a good time to buy in to the sector. John Stepek explains ho…
24 Apr 2014